Tuesday, October 7, 2014 from 6:00 PM to 8:00 PM (EDT)
Rockville, Maryland
In February 2013, The Sunshine Act was included as the Transparency Reports and Reporting of Physician Ownership or Investment Interests section of the Patient Protection and Affordable Care Act (ACA). The Sunshine Act requires manufacturers of drugs, medical devices, and biologicals that participate in U.S. federal healthcare programs to report certain payments and items of value (typically $10 or more and totaling $100 annually or greater) given to physicians and teaching hospitals. Failure to stay in compliance may result in fines ranging from $10,000 to $1,000,000 annually. Whether you are a practicing physician or your startup has a medical device, drug, or related product, you are impacted by the ACA’s Physician Payments Sunshine Act. In July, CMS proposed removing the reporting exemption for any payments or transfers of value made to physicians who participate in accredited CME programs. We’ll talk with experts in compliance and policy who will share their experiences in implementing these new policies and how you can understand the implications of the law, dispute inaccuracies, and stay in compliance!